Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

In advance of this week's CDC vaccine advisory meeting, HHS Secretary Robert F. Kennedy Jr. restacked the committee, claiming ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

RFK Jr.’s newly appointed CDC vaccine panel will not review HPV or meningitis vaccines but will vote on thimerosal, a ...

vaccine effectiveness from October 2023 to March 2024 against RSV-associated hospitalization reached 75% (95% CI 50-87), according to researchers led by Diya Surie, MD, of the CDC in Atlanta.

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week, but their agenda suggests they’ll skip ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

U.S. vaccine advisers will discuss recommendations for flu vaccines containing the preservative thimerosal and a combination measles shot for children this month, putting topics of concern to Health ...

A senior scientist at the U.S. Centers for Disease Control and Prevention has resigned, warning that changes in leadership ...